Advanced Heart Failure Comprehensive Care Center | Patient Education

De Marco T, Chatterjee K. Phosphodiesterase inhibitors in refractory heart failure: Bridge to ß-blockade? J Am Coll Cardiol.

Shinbane JS, Chu E, De Marco T, Sobol Y, Fitzpatrick AP, Lau DM, Klinski C, Schiller J, Griffin JC, Chatterjee KC. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol

De Marco T, Goldman L. Predicting outcomes in severe heart failure. Editorial. Circulation

Chatterjee K, De Marco T. Management of Refractory Heart Failure. In Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS (eds): Heart Failure Scientific Principles and Clinical Practice. New York, NY, Churchill Livingstone Inc

De Marco T, Chatterjee, K. Refractory heart failure: A therapeutic approach. J Intensive Care Med

Chou T, Sudhir K, Amidon T, Klinski C, De Marco T, Chatterjee K, Botvinick EH. Adenosine produces greater coronary hyperemic response in heart transplant recipients in comparison to dipyridamole. Am J Cardiol

Sudhir K, De Marco T, Kumar S, Maganti K, Amidon TM, de Groot CJ, Klinski C, Lau D, Keith F, Taylor RN, et al. Transcoronary and pulmonary vascular dynamics of endothelin-1 in cardiac transplant recipients. J Heart Lung Transplant

Chatterjee K, De Marco T. Treatment of Symptomatic Heart Failure In Dhalla NS, Beamish RE, Takeda N, Nagano M (eds): The Failing Heart. New York, NY, Raven Press, Ltd.

Barbant SD, Redberg RF, Tucker KJ, Chatterjee K, De Marco T, Foster E, Schiller NB. Abnormal pulmonary artery pressure profile after cardiac transplantation: An exercise Doppler echocardiographic study. Am Heart J

Sudhir K, MacGregor JS, De Marco T, De Groot CJM, Taylor RN, Chou TM, Yock PG, Chatterjee K. Cyclosporin impairs release of endothelin derived relaxing factor in epicardial and resistance coronary arteries. Circulation